Convening the Entire Precision Medicine Ecosystem to Tackle the Drug-Diagnostic Value Chain
The precision medicine field is vast, which is why our team has meticulously researched with subject matter experts to identify the key challenges facing the community across indications, biomarkers, biopsy types, testing technologies and drug modalities.
With the expansion to five end-to-end content tracks, Biomarker Discovery & Translation, Clinical & CDx Development, Rx-Dx Commercialization & Adoption, Digital Pathology & Spatial Biomarkers and Multimodal & AI‑Enabled Precision Medicine, our speakers will tailor their presentations to the specific challenges facing you at each stage of development.
Take a quick look at our new track structure:
Track 1: Biomarker Discovery & Translation
Explore dynamic tumor profiling, functional, ligand-binding, pathology and genomic assays, and the biomarker operations and pre-analytics underwriting these programs.
This track is targeted at those with expertise in:
- Translation Development
- Biomarker Discovery
- Biomarker Operations
- Oncology
Track 2: Clinical & CDx Development
Strengthen biomarker‑driven trial design, global enrolment, IVD validation and novel endpoint integration for regulatory compliant Rx-Dx co‑development.
This track is for those working in:
- Clinical Development
- Medical Affairs
- CDx Development
- Strategic Partnerships
- Regulatory Teams
Track 3: Rx-Dx Commercialization & Adoption
Navigate coverage shifts, international payer evidence needs, pricing, and launch sequencing to enable scalable, equitable, and regionally aligned diagnostic access at therapeutic launch.
This track is aimed at teams across:
- Pricing & Reimbursement
- Market Access
- HEOR
- Commercialization
Track 4: Digital Pathology & Spatial Biomarkers (NEW)
Unlock digital pathology, spatial transcriptomic biomarkers and cloud integrated workflows, standardization and automation, to enhance diagnostic accuracy, throughput and reproducibility.
This track is designed for experts in:
- Digital Pathology
- Imaging
- Spatial Biology
- CDx Development
Track 5: Multimodal & AI‑Enabled Precision Medicine (NEW)
Integrate multimodal datasets, train foundational models and deploy validated AI/ML models to generate and operationalize predictive biomarkers and endpoints in trials.
This track is curated for those specializing in:
- Data Science
- RWE
- Multimodal
- AI & Analytics
- Digital Innovation
Delve into the Brand-New Agenda
- Free* Attendance for Representatives from Biopharma & Academia
- Your Globally Leading Biomarker & Companion Diagnostics Forum
- Access Numerous Strategic Rx-Dx Co-Development & Partnership Selection Panels
- Partake in Multiple Biomarker Sessions Spanning Oncology, Hematology & Neurological, Chronic, Autoimmune & Rare Diseases
- Discover Brand-New Case Studies on Digital Pathology, Multimodal Data & AI-Enabled Precision Medicine
- Take Advantage of Unmatched, Exclusive Networking & Partnerships Opportunities
